よむ、つかう、まなぶ。
【参考資料２－４】抗微生物薬適正使用の手引き 第四版（案）歯科編 (31 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64503.html |
| 出典情報 | 厚生科学審議会 感染症部会（第99回 10／21）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
抗微生物薬適正使用の手引き
第四版
歯科編
69. Martins JR, et al; The Use of Antibiotics in Odontogenic Infections: What Is the Best
Choice? A Systematic Review. J Oral Maxillofac Surg. 2017. 75: 2606.e1-2606. e6.
70. Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal,
Antiparasitic, and Antiviral Drugs, Seventh Edition
71. サンフォード感染症治療ガイド. アクセス日：2025/1/28
72. Johns Hopkins Abx Guide. アクセス日：2025/1/28
73. Shehab N, et a. Emergency department visits for antibiotic-associated adverse
events. Clin Infect Dis. 2008. 47(6):735–743.
74. Versporten A, et al. European Surveillance of Antimicrobial Consumption (ESAC):
outpatient penicillin use in Europe (1997-2009). J Antimicrob Chemother. 2011. 66 Suppl
6: vi13–vi23.
75. Seidelman JL, et al. 2023. Surgical Site Infection Prevention: A
Review. JAMA. 329(3):244-252.
76. Blumenthal KG, et al. Antibiotic allergy. Lancet. 2019. 393(10167):183-198.
77. Stone CA Jr, et al. The challenge of de-labeling penicillin allergy. Allergy.
2020. 75(2):273-288.
78. MacFadden DR, et al. Impact of Reported Beta-Lactam Allergy on Inpatient Outcomes: A
Multicenter Prospective Cohort Study. Clin Infect Dis. 2016. 63(7):904-910.
79. Blumenthal KG, et al. Risk of meticillin resistant Staphylococcus aureus and Clostridium
difficile in patients with a documented penicillin allergy: population based matched
cohort study. BMJ. 2018. 361:k2400.
80. Sakoulas G, et al. Is a Reported Penicillin Allergy Sufficient Grounds to Forgo the
Multidimensional Antimicrobial Benefits of β-Lactam Antibiotics?. Clin Infect Dis.
2019. 68(1): 157-164.
81. Koizumi R, et al. Effects of the cefazolin shortage on the sales, cost, and appropriate
use of other antimicrobials. BMC Health Serv Res. 2021. 21(1):1118.
82. Uda A. et al. Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with
Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus in a Tertiary Care
University Hospital. Antibiotics. 2021. 10(10):1247.
83. Honda H, et al. Critical National Shortage of Cefazolin in Japan: Management
Strategies. Clin Infect Dis. 2020. 71(7):1783-1789.
84. Nakarai H, et al. The Impact of Cefazolin Shortage on Surgical Site Infection Following
Spine Surgery in Japan. Spine. 2021. 46(14):923-930.
85. 医薬品データベースライブラリー. データインデックス株式会社.
https://drugshortage.jp/index.php
31
第四版
歯科編
69. Martins JR, et al; The Use of Antibiotics in Odontogenic Infections: What Is the Best
Choice? A Systematic Review. J Oral Maxillofac Surg. 2017. 75: 2606.e1-2606. e6.
70. Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal,
Antiparasitic, and Antiviral Drugs, Seventh Edition
71. サンフォード感染症治療ガイド. アクセス日：2025/1/28
72. Johns Hopkins Abx Guide. アクセス日：2025/1/28
73. Shehab N, et a. Emergency department visits for antibiotic-associated adverse
events. Clin Infect Dis. 2008. 47(6):735–743.
74. Versporten A, et al. European Surveillance of Antimicrobial Consumption (ESAC):
outpatient penicillin use in Europe (1997-2009). J Antimicrob Chemother. 2011. 66 Suppl
6: vi13–vi23.
75. Seidelman JL, et al. 2023. Surgical Site Infection Prevention: A
Review. JAMA. 329(3):244-252.
76. Blumenthal KG, et al. Antibiotic allergy. Lancet. 2019. 393(10167):183-198.
77. Stone CA Jr, et al. The challenge of de-labeling penicillin allergy. Allergy.
2020. 75(2):273-288.
78. MacFadden DR, et al. Impact of Reported Beta-Lactam Allergy on Inpatient Outcomes: A
Multicenter Prospective Cohort Study. Clin Infect Dis. 2016. 63(7):904-910.
79. Blumenthal KG, et al. Risk of meticillin resistant Staphylococcus aureus and Clostridium
difficile in patients with a documented penicillin allergy: population based matched
cohort study. BMJ. 2018. 361:k2400.
80. Sakoulas G, et al. Is a Reported Penicillin Allergy Sufficient Grounds to Forgo the
Multidimensional Antimicrobial Benefits of β-Lactam Antibiotics?. Clin Infect Dis.
2019. 68(1): 157-164.
81. Koizumi R, et al. Effects of the cefazolin shortage on the sales, cost, and appropriate
use of other antimicrobials. BMC Health Serv Res. 2021. 21(1):1118.
82. Uda A. et al. Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with
Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus in a Tertiary Care
University Hospital. Antibiotics. 2021. 10(10):1247.
83. Honda H, et al. Critical National Shortage of Cefazolin in Japan: Management
Strategies. Clin Infect Dis. 2020. 71(7):1783-1789.
84. Nakarai H, et al. The Impact of Cefazolin Shortage on Surgical Site Infection Following
Spine Surgery in Japan. Spine. 2021. 46(14):923-930.
85. 医薬品データベースライブラリー. データインデックス株式会社.
https://drugshortage.jp/index.php
31